Canopy Growth and its medical brand Spectrum Therapeutics today introduced new 30- and 90-pack softgel formats across their minor-cannabinoid portfolio — larger pack sizes designed to improve value, support adherence and give clinicians more room to optimize a patient's treatment over time.
The expanded range spans both daytime and nighttime needs. Daytime options include Clarity (CBD:CBG 1:1) and Daily Relief variations, while nighttime options include Unwind (CBD:CBN 2:1) and a new Nighttime Relief formulation (CBN:CBD:THC 1:1:2). Developed in response to clinic feedback, a higher-dose Daily Relief 30-pack (a 5:2:2 ratio) joins the lineup for patients who need stronger daytime support.
Most products are available immediately, with the Daily Relief 30-pack and Nighttime Relief 90-pack launching at the end of May. "This expansion goes beyond pack size," said Andrew Bevan, who leads Canopy's medical business, describing it as innovation that delivers dosing flexibility, improves affordability and responds directly to clinician feedback on efficacy and treatment optimization.
This release was originally distributed via canopygrowth.com.
All news releases